Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Testosterone treatment may affect heart response to stress in transgender men.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Dermatology trainees lack standardized guidelines and education for treating testosterone-induced skin conditions in transmasculine individuals.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

Australia needs better dermatological guidelines for gender-diverse patients.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Topical 3% minoxidil effectively and safely enhances facial hair in transgender men.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Progesterone may help trans women with breast development and health, but more research is needed.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.